Skip to search.
 FTSE 100 Down 1.32%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
8.37 Down 0.32(3.68%) 18:18 - Nasdaq Real Time Price
Prev Close:8.69
Open:8.72
Bid:8.36 x 600
Ask:8.37 x 1800
1y Target Est:10.89
Beta:2.20645
Earnings Date:3 Nov - 7 Nov (Est.)
Day's Range:8.35 - 8.77
52wk Range:5.57 - 10.95
Volume:1,302,869
Avg Vol (3m):1,438,300
Market Cap:1.14b
P/E (ttm):170.82
EPS (ttm):0.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ACHN at this time.

Comparison

Symbol% ChgMkt Cap
ACHNDown 3.68%1.14b
GSKDown 0.95%104.53b
JNJDown 0.90%322.12b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.61
Quarterly EPS Est (Sep-16) :-0.16
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-0.81

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecule drug therapies for infectious diseases and immune system disorders in the United States and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback